z-logo
open-access-imgOpen Access
Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis
Author(s) -
Fatih M. Uckun,
Muhammad Saeed,
Mustafa Awili,
İbrahim H. Özercan,
Sanjive Qazi,
Cynthia Lee,
Adeel Shibli,
Alan Skolnick,
Alonso Prusmack,
Joseph Varón,
César I Elizalde Barrera,
Cemal Orhan,
Michael Völk,
Kazım Şahin
Publication year - 2022
Publication title -
future microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.797
H-Index - 82
eISSN - 1746-0921
pISSN - 1746-0913
DOI - 10.2217/fmb-2022-0044
Subject(s) - dexamethasone , sepsis , tolerability , medicine , pharmacology , gastroenterology , adverse effect

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom